M

Medpace Holdings

MEDP

385.09
USD
1.69
(0.44%)
مغلق
حجم التداول
58,491
الربح لكل سهم
0
العائد الربحي
0
P/E
31
حجم السوق
10,121,764,949
أصول ذات صلة
A
ALGN
-3.810
(-1.64%)
228.270 USD
A
AMN
-0.735
(-1.09%)
66.890 USD
E
EHC
0.060
(0.06%)
93.000 USD
H
HSTM
0.095
(0.32%)
29.865 USD
K
KMDA
-0.17000
(-3.01%)
5.48000 USD
M
MDRX
0
(0%)
0.000000 USD
O
OMCL
9.590
(32.79%)
38.840 USD
S
SRDX
-0.060
(-0.14%)
41.350 USD
الأخبار المقالات

العنوان: Medpace Holdings

القطاع: Healthcare
الصناعة: Diagnostics & Research
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.